← Leaderboards
Frederick Lewis Altice
Yale University
$47,021,698
Attributed
$56,405,640
Total exposure
26
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$55,714,580 · 24
CDC$691,060 · 1
SAMHSA$0 · 1
By mechanism
R01$47,953,139 · 14
D43$2,512,389 · 2
R21$2,111,649 · 5
K24$1,549,665 · 1
R33$935,951 · 1
UR6$691,060 · 1
Top collaborators
- Lynn Madden11 shared
- Sandra Ann Springer8 shared
- Adeeba Kamarulzaman6 shared
- Zhao Ni5 shared
- Denise Esserman4 shared
- Judith E Feinberg4 shared
- Irma Kirtadze4 shared
- Ana Lucia Seminario1 shared
Most similar at Yale University
Same institution · by research overlap
- Lynn Madden$2,721,391
- Sandra Ann Springer$27,149,168
- Zhao Ni$661,674
- Ronald Scott Braithwaite$34,131,274
- Daniel J Bromberg$171,638
Others in their field
Top investigators on “Epidemic”
- Wafaa M. El-Sadr · Columbia University Health Sciences$283,046,219
- Lawrence Corey · Fred Hutchinson Cancer Center$281,869,217
- Myron S Cohen · Family Health International$206,489,087
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$189,394,849
- Carol Nesel · Westat$188,148,170
- Deborah J Donnell · Fred Hutchinson Cancer Center$161,574,659
Research focus
EpidemicCaringAids PreventionCommunitiesPharmaceutical PreparationsTransmission ProcessPrevalenceInjecting Drug UserHiv InfectionsResearch PersonnelAddictionCountryAntiretroviral TherapyProgramsBaseTrainingScale UpPrisonerInternationalInnovationPrisonsEvidence Based InterventionCollaborationsDrug Usage
Grant awards (127)
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings$1,144,825
R01 · FY2025 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$634,227
R01 · FY2025 · DA · contact PI
Innovations in Implementing Decentralized HIV Services in Peru$478,951
R01 · FY2025 · AI · contact PI
Expanding Medication Assisted Therapies in Central Asia$343,625
R01 · FY2025 · DA · contact PI
Georgian Implementation Science Fogarty Training Program (GIFT)$287,125
D43 · FY2025 · TW · contact PI
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention$224,738
R01 · FY2025 · TW · contact PI
Innovations in Implementing Decentralized HIV Services in Peru$210,200
R01 · FY2025 · AI · contact PI
Expanding Medication Assisted Therapies in Central Asia$76,762
R01 · FY2025 · DA · contact PI
Expanding Medication Assisted Therapies in Central Asia$74,019
R01 · FY2025 · DA · contact PI
Expanding Medication Assisted Therapies in Central Asia$70,000
R01 · FY2025 · DA · contact PI
Innovations in Implementing Decentralized HIV Services in Peru$706,168
R01 · FY2024 · AI · contact PI
Prison Interventions and HIV Prevention Collaboration$639,387
R01 · FY2024 · DA · contact PI
Expanding Medication Assisted Therapies in Central Asia$571,007
R01 · FY2024 · DA · contact PI
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia$310,685
R33 · FY2024 · TW
Malaysian Implementation Science Training (MIST) Program in HIV$297,920
D43 · FY2024 · TW · contact PI
Georgian Implementation Science Fogarty Training Program (GIFT)$289,410
D43 · FY2024 · TW · contact PI
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention$214,550
R01 · FY2024 · TW · contact PI
Identifying Challenges and Opportunities for PrEP Uptake Among Women at Elevated HIV Risk in Georgia$100,000
D43 · FY2024 · TW · contact PI
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention$100,000
R01 · FY2024 · TW · contact PI
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings$1,155,157
R01 · FY2023 · DA · contact PI
Innovations in Implementing Decentralized HIV Services in Peru$723,611
R01 · FY2023 · AI · contact PI
Prison Interventions and HIV Prevention Collaboration$635,537
R01 · FY2023 · DA · contact PI
Expanding Medication Assisted Therapies in Central Asia$572,514
R01 · FY2023 · DA · contact PI
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia$311,997
R33 · FY2023 · TW
Malaysian Implementation Science Training (MIST) Program in HIV$297,992
D43 · FY2023 · TW · contact PI
Georgian Implementation Science Fogarty Training Program (GIFT)$291,266
D43 · FY2023 · TW · contact PI
Reducing Stigma in People Who Inject Drugs with HIV Using a Rapid Start Antiretroviral Therapy Intervention$170,262
R01 · FY2023 · TW · contact PI
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings$1,165,515
R01 · FY2022 · DA · contact PI
Expanding Medication Assisted Therapies in Central Asia$625,373
R01 · FY2022 · DA · contact PI
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia$313,269
R33 · FY2022 · TW
Malaysian Implementation Science Training (MIST) Program in HIV$298,057
D43 · FY2022 · TW · contact PI
Integrating Addiction and Infectious Diseases Services into Primary Care in Rural Settings$1,198,725
R01 · FY2021 · DA · contact PI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine$792,012
R01 · FY2021 · DA · contact PI
Vitamin D and Alcohol Use Disorder on Progression of Dental Disease in MSM with and without HIV$651,787
R56 · FY2021 · DE
Expanding Medication Assisted Therapy in Ukraine (ExMAT)$615,610
R01 · FY2021 · DA · contact PI
Malaysian Implementation Science Training (MIST) Program in HIV$295,818
D43 · FY2021 · TW · contact PI
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia$186,446
R21 · FY2021 · TW
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia$159,695
R21 · FY2021 · DA · contact PI
Malaysian Implementation Science Training (MIST) Program in HIV$56,672
D43 · FY2021 · TW · contact PI
Expanding Medication Assisted Therapy in Ukraine (ExMAT)$658,981
R01 · FY2020 · DA · contact PI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings$628,929
R01 · FY2020 · DA · contact PI
Malaysian Implementation Science Training (MIST) Program in HIV$298,129
D43 · FY2020 · TW · contact PI
Modeling the impact and cost-effectiveness of opioid agonist treatments to reduce the negative consequences of incarceration on HIV and TB transmission in Eastern Europe and Central Asia$218,421
R21 · FY2020 · DA · contact PI
Developing an artificial intelligence-based mHealth intervention to increase HIV testing in Malaysia$200,951
R21 · FY2020 · TW
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine$894,523
R01 · FY2019 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$660,401
R01 · FY2019 · DA · contact PI
Expanding Medication Assisted Therapy in Ukraine (ExMAT)$653,611
R01 · FY2019 · DA · contact PI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine$917,630
R01 · FY2018 · DA · contact PI
Expanding Medication Assisted Therapy in Ukraine (ExMAT)$708,464
R01 · FY2018 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$660,401
R01 · FY2018 · DA · contact PI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings$656,887
R01 · FY2018 · DA · contact PI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine$882,615
R01 · FY2017 · DA · contact PI
Expanding Medication Assisted Therapy in Ukraine (ExMAT)$769,707
R01 · FY2017 · DA · contact PI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings$727,222
R01 · FY2017 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$660,401
R01 · FY2017 · DA · contact PI
Modeling HCV/HIV transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs$258,852
R21 · FY2017 · DA · contact PI
Improving Antiretroviral Adherence and Persistence using mHealth Tools in HIV-infected Cocaine Users$251,250
R21 · FY2017 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$8,467
R01 · FY2017 · DA · contact PI
Integrating Addiction Treatment and HIV Services into Primary Care Clinics in Ukraine$886,533
R01 · FY2016 · DA · contact PI
Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings$677,593
R01 · FY2016 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$653,796
R01 · FY2016 · DA · contact PI
Expanding Medication Assisted Therapies in Ukraine$532,856
R01 · FY2016 · DA · contact PI
Modeling HCV/HIV transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs$221,514
R21 · FY2016 · DA · contact PI
Improving Antiretroviral Adherence and Persistence using mHealth Tools in HIV-infected Cocaine Users$209,375
R21 · FY2016 · DA · contact PI
Expanding Medication Assisted Therapies in Ukraine$8,467
R01 · FY2016 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$677,026
R01 · FY2015 · DA · contact PI
Expanding Medication Assisted Therapies in Ukraine$534,428
R01 · FY2015 · DA · contact PI
HIV, Buprenorphine, and the Criminal Justice System$164,835
R01 · FY2015 · DA · contact PI
Expanding Medication Assisted Therapies in Ukraine$164,635
R01 · FY2015 · DA · contact PI
Expanding Medication Assisted Therapies in Ukraine$7,927
R01 · FY2015 · DA · contact PI
HIV, Buprenorphine, and the Criminal Justice System$611,814
R01 · FY2014 · DA · contact PI
Expanding Medication Assisted Therapies in Ukraine$565,418
R01 · FY2014 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$394,709
R01 · FY2014 · DA · contact PI
HIV, Buprenorphine, and the Criminal Justice System$845,338
R01 · FY2013 · DA · contact PI
Alcohol Pharmacotherapies Among Released Prisoners$704,307
R01 · FY2013 · AA
Expanding Medication Assisted Therapies in Ukraine$544,278
R01 · FY2013 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$381,667
R01 · FY2013 · DA · contact PI
HIV, Buprenorphine, and the Criminal Justice System$782,808
R01 · FY2012 · DA · contact PI
Alcohol Pharmacotherapies Among Released Prisoners$774,586
R01 · FY2012 · AA
Expanding Medication Assisted Therapies in Ukraine$587,566
R01 · FY2012 · DA · contact PI
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia$503,987
R01 · FY2012 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$400,112
R01 · FY2012 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$181,332
K24 · FY2012 · DA · contact PI
HIV, Buprenorphine, and the Criminal Justice System$79,680
R01 · FY2012 · DA · contact PI
Project CHOICES$0
H79 · FY2012 · SU · contact PI
Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations$822,487
R01 · FY2011 · DA
HIV, Buprenorphine, and the Criminal Justice System$774,518
R01 · FY2011 · DA · contact PI
Alcohol Pharmacotherapies Among Released Prisoners$760,400
R01 · FY2011 · AA
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia$518,077
R01 · FY2011 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$424,221
R01 · FY2011 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$181,332
K24 · FY2011 · DA · contact PI
HIV, Buprenorphine, and the Criminal Justice System$164,376
R01 · FY2011 · DA · contact PI
Project CHOICES$0
H79 · FY2011 · SU · contact PI
Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations$780,884
R01 · FY2010 · DA
Alcohol Pharmacotherapies Among Released Prisoners$761,595
R01 · FY2010 · AA
HIV, Buprenorphine, and the Criminal Justice System$599,833
R01 · FY2010 · DA · contact PI
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia$505,203
R01 · FY2010 · DA · contact PI
Prison Interventions and HIV Prevention Collaboration$452,071
R01 · FY2010 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$181,332
K24 · FY2010 · DA · contact PI
Alcohol Pharmacotherapies Among Released Prisoners$41,210
R01 · FY2010 · AA
Project CHOICES$0
H79 · FY2010 · SU · contact PI
Alcohol Pharmacotherapies Among Released Prisoners$760,029
R01 · FY2009 · AA
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia$558,948
R01 · FY2009 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$179,748
K24 · FY2009 · DA · contact PI
Project CHOICES$0
H79 · FY2009 · SU · contact PI
Directly Observed Therapy for Community-Released HIV-positive Prisoners$591,499
R01 · FY2008 · DA · contact PI
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia$581,793
R01 · FY2008 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$175,161
K24 · FY2008 · DA · contact PI
Project CHOICES$0
H79 · FY2008 · SU · contact PI
Directly Observed Therapy for Community-Released HIV-positive Prisoners$675,598
R01 · FY2007 · DA · contact PI
PS06-011, HIV Prevention Research with HIV+ Incarcerated Populations$400,000
UR6 · FY2007 · PS · contact PI
Improving Health Outcomes for Released HIV+ Prisoners$207,413
R21 · FY2007 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$136,338
K24 · FY2007 · DA · contact PI
Direct/Observed Therapy/Community-Released HIV+Prisoners$668,506
R01 · FY2006 · DA · contact PI
HIV Prevention Research with HIV+ Incarcerated Populations$291,060
UR6 · FY2006 · PS · contact PI
Improving Health Outcomes for Released HIV+ Prisoners$197,732
R21 · FY2006 · DA · contact PI
Enhancing Health Outcomes Among HIV+ Substance Abusers$133,154
K24 · FY2006 · DA · contact PI
Direct/Observed Therapy/Community-Released HIV+Prisoners$718,074
R01 · FY2005 · DA
Enhancing Health Outcomes Among HIV+ Substance Abusers$130,062
K24 · FY2005 · DA
Direct/Observed Therapy/Community-Released HIV+Prisoners$607,238
R01 · FY2004 · DA
Enhancing Health Outcomes Among HIV+ Substance Abusers$127,060
K24 · FY2004 · DA
DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D$88,034
R01 · FY2004 · DA
DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D$468,208
R01 · FY2003 · DA
Enhancing Health Outcomes Among HIV+ Substance Abusers$124,146
K24 · FY2003 · DA
DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D$512,245
R01 · FY2002 · DA
DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D$505,699
R01 · FY2001 · DA
DIRECTLY OBSERVED ANTI RETROVIRAL THERAPY AMONG ACTIVE D$497,013
R01 · FY2000 · DA